BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3431730)

  • 1. [Respiratory functional decline after 5 years in patients with silicosis and asbestosis].
    Avolio G; Bucca C; Rolla G; Oliaro A; Cacciabue M; Caria E; Arrigoni P; Barbalonga A
    Minerva Med; 1987 Dec; 78(24):1845-8. PubMed ID: 3431730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced sputum markers of fibrosis and decline in pulmonary function in asbestosis and silicosis: a pilot study.
    Prince P; Boulay ME; Pagé N; Desmeules M; Boulet LP
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):813-9. PubMed ID: 18544209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung function in different types of pneumoconiosis.
    Marek K
    Z Erkr Atmungsorgane; 1985; 164(3):270-2. PubMed ID: 3925650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic activity of sera from silicosis and pulmonary Langerhans cell histiocytosis patients in relation to lung function tests.
    Zielonka TM; Demkow U; Filewska M; Bialas-Chromiec B; Zycinska K; Radzikowska E; Korzeniewska M; Wardyn KA; Kus J; Skopinska-Rozewska E
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():781-9. PubMed ID: 19218705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interpretation of pneumoconiosis--results of cardiopulmonary function tests in dust-exposed patients with and without silicosis].
    Bürkmann I; Julich H
    Z Erkr Atmungsorgane; 1985; 164(2):162-72. PubMed ID: 4013401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lysosomal enzyme activities in silicosis and asbestosis.
    Koskinen H; Järvisalo J; Huuskonen MS; Koivula T; Mutanen P; Pitkänen E
    Eur J Respir Dis; 1983 Apr; 64(3):182-8. PubMed ID: 6840231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-breath total lung capacity determinations in patients with non-obstructive lung disease.
    Teculescu DB
    Bull Physiopathol Respir (Nancy); 1974; 10(2):147-61. PubMed ID: 4415780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pilot study of the prevalence of a hyperreactive bronchial system in various occupationally-induced lung diseases].
    Triebig G; Roschning H; Weltle D
    Pneumologie; 1990 Jun; 44(6):815-21. PubMed ID: 2381888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
    Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of respiratory function in pulmonary silicosis. The ventilation-perfusion ratio and its functional correlations].
    Dotta F; Bianchi A; Marucci V
    Zacchia; 1968; 4(2):245-57. PubMed ID: 5719588
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung function changes in pleural asbestosis.
    Petrović P; Ostojić L; Perić I; Mise K; Ostojić Z; Bradarić A; Bota B; Janković S; Tocilj J
    Coll Antropol; 2004 Dec; 28(2):711-5. PubMed ID: 15666603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon monoxide transfer factor for the lung in silicosis.
    Teculescu DB; Stănescu DC
    Scand J Respir Dis; 1970; 51(3):150-9. PubMed ID: 5508403
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional implications of BAL in the presence of restrictive or obstructive lung disease.
    Pedreira WL; de Souza R; Fiks IN; Salge JM; de Carvalho CR
    Respir Med; 2007 Jun; 101(6):1344-9. PubMed ID: 17118639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise testing in occupational lung diseases.
    Wiedemann HP; Gee JB; Balmes JR; Loke J
    Clin Chest Med; 1984 Mar; 5(1):157-71. PubMed ID: 6723238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of the loss of pulmonary function in patients with silicosis--a retrospective analysis by experts].
    Barthel E
    Pneumologie; 1990 Jul; 44(7):883-6. PubMed ID: 2399236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory drive and ventilatory pattern during exercise in interstitial lung disease.
    Van Meerhaeghe A; Scano G; Sergysels R; Bran M; De Coster A
    Bull Eur Physiopathol Respir; 1981; 17(1):15-26. PubMed ID: 7470683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.
    Plastiras SC; Karadimitrakis SP; Ziakas PD; Vlachoyiannopoulos PG; Moutsopoulos HM; Tzelepis GE
    Arthritis Rheum; 2006 Aug; 55(4):598-602. PubMed ID: 16874782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can airway obstruction be estimated by lung auscultation in an emergency room setting?
    Leuppi JD; Dieterle T; Wildeisen I; Martina B; Tamm M; Koch G; Perruchoud AP; Leimenstoll BM
    Respir Med; 2006 Feb; 100(2):279-85. PubMed ID: 15964751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary function in long-term survivors of testicular cancer.
    Haugnes HS; Aass N; Fosså SD; Dahl O; Brydøy M; Aasebø U; Wilsgaard T; Bremnes RM
    J Clin Oncol; 2009 Jun; 27(17):2779-86. PubMed ID: 19414680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.